" class="no-js "lang="en-US"> Genezen Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Genezen Announces the Appointment of Key Executive Leaders, Expanding Viral Vector Capabilities

Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO), today announced the […]

Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth

Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more